Patient input, safety focus urged for final PDUFA V touchups
25 October 2011
Donna Young
Please Login to read the full article.
25 October 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- PDUFA V deal adds 60-day cushion for new drug, biologic reviews
- US Capitol Capsule: Will PDUFA V be a 'damned if it does, damned if it doesn't' scenario for FDA?
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
- User fee bill advances in Senate, but House puts on brakes
ANALYSIS
Other Informa Analysis
FEATURES
- Chinese producers may be losing price edge to India, says Granules MD
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
